WASHINGTON (AP) -- Scientists say they've created a drug that promises to prevent radiation damage from cancer treatment.
They say the drug could even offer an antidote during a nuclear emergency.
Researchers report a single dose of the experimental drug protected both mice and monkeys from what should have been lethal doses of radiation. A company called Cleveland Biolabs is working to bring the drug to market.
The research is still in the early stages. But many people are closely watching the project. The Defense Department and other government agencies are also helping to fund it.
A study to see if the compound is safe in people could begin as soon as this summer.
The findings are published in tomorrow's edition of the journal Science.
(Copyright 2008 by The Associated Press. All Rights Reserved.)
To comment, the following rules must be followed:
Comments may be monitored for inappropriate content, but the station is under no legal obligation to do so.
If you believe a comment violates the above rules, please use the Flagging Tool to alert a Moderator.
Flagging does not guarantee removal.
Multiple violations may result in account suspension.
Decisions to suspend or unsuspend accounts are made by Station Moderators.
Links require admin approval before posting.
Questions may be sent to firstname.lastname@example.org. Please provide detailed information.
Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or email@example.com.